Delivery Order SPE2DR25D3013-SPE2DR26F6T5M
- Not listed
- The Defense Logistics Agency awarded a $4,839.72 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract is expected to be completed by September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,848.75 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors. This competitive, firm fixed-price delivery order is scheduled for completion by August 21, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's larger pharmaceutical supply framework with the federal...
- The Defense Logistics Agency awarded a $1,525.20 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 19, 2025. The work is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small transaction within the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $5,144.31. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $13,438.83 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens (semaglutide injection). The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by November 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a $43,449.54 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 ml pen injectors on September 24, 2025, with a completion date of September 25, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a single-transaction purchase under the company's broader relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $8,463.35 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections on December 3, 2025, with a completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services through AmerisourceBergen's larger contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,613.59 to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with an ultimate completion date of December 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $2,214.84 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injections on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens in 0.5 mL quantities, with a ceiling value of $1,476.56 and an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6T5MDelivery Order
The Defense Logistics Agency awarded a $3,330.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. The contract is scheduled for completion by December 2, 2025, with performance to take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. This delivery order represents a child contract under AmerisourceBergen Drug Corp's significant $999.999 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The indefinite delivery vehicle enables flexible procurement of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 11/30/25 |